Related Experiment Video
Updated: Aug 6, 2025

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Anti-aging Strategies and Topical Delivery of Biopolymer-based Nanocarriers for Skin Cancer Treatment
Jino Affrald Ramaraj1, Shoba Narayan1
1Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, 603103, India.
Abstract:
Environmental factors like UV radiation and epigenetic changes are significant factors for skin cancer that trigger early aging. This review provides essential information on cancer development concerning aging, the receptors involved, and the therapeutic targets. Biopolymers like polysaccharide, polyphenols, proteins, and nucleic acid plays a vital role in the regulation of normal cell homeostasis. Therefore, it is pertinent to explore the role of biopolymers as antiaging formulations and the possibility of these formulations being used against cancer via topical administrations. As UV radiation is one of the predominant factors in causing skin cancer, the association of receptors between aging and cancer indicated that insulin receptor, melatonin receptor, toll-like receptor, SIRT 1 receptor, tumor-specific T cell receptor and mitochondria-based targeting could be used to direct therapeutics for suppression of cancer and prevent aging. Biopolymer-based nanoformulations have tremendously progressed by entrapment of drugs like curcumin and resveratrol which can prevent cancer and aging simultaneously. Certain protein signaling or calcium and ROS signaling pathways are different for cancer and aging. The involvement of mitochondrial DNA mutation along with telomere shortening with a change in cellular energetics leading to genomic instability in the aging process can also induce mitochondrial dysfunction and epigenetic alterations leading to skin cancer. Therefore, the use of biopolymers as a topical supplement during the aging process can result in the prevention of cancer.
Insights
Biopolymers can be used in topical anti-aging formulations to help prevent skin cancer. These natural compounds target key receptors involved in both aging and cancer development, offering a dual therapeutic approach.
Area of Science:
- Dermatology and Oncology
- Biotechnology and Aging Research
Background:
- Environmental factors like UV radiation and epigenetic changes accelerate skin aging and contribute to skin cancer.
- Biopolymers (polysaccharides, polyphenols, proteins, nucleic acids) are crucial for maintaining normal cell homeostasis.
- Aging and skin cancer share common pathways and molecular targets, including specific receptors and signaling cascades.
Purpose of the Study:
- To review the role of biopolymers in anti-aging formulations.
- To explore the potential of topical biopolymer formulations for skin cancer prevention.
- To identify shared therapeutic targets between aging and cancer.
Main Methods:
- Literature review focusing on environmental factors, aging, cancer development, and biopolymers.
- Analysis of receptor associations between aging and cancer (e.g., insulin, melatonin, toll-like, SIRT 1 receptors).
- Examination of biopolymer-based nanoformulations and their therapeutic potential.
Main Results:
- Biopolymers play a vital role in regulating cell homeostasis and show potential as anti-aging agents.
- Shared receptors and pathways between aging and cancer suggest dual-targeting therapeutic strategies.
- Biopolymer-based nanoformulations, like those containing curcumin and resveratrol, demonstrate promise in preventing both aging and cancer.
Conclusions:
- Topical biopolymer supplements during aging may prevent skin cancer.
- Targeting shared receptors and pathways offers a novel approach for simultaneous cancer and aging prevention.
- Biopolymer nanoformulations represent a promising strategy for dual therapeutic intervention against skin aging and cancer.
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells

